MIRA INFORM REPORT

 

 

Report Date :           

15.03.2012

 

IDENTIFICATION DETAILS

 

Name :

CIMED INDÚSTRIA DE MEDICAMENTOS LTDA

 

 

Registered Office :

Rua Engenheiro Prudente, 121 - Vila Monumento , Zip Code 01550-000 - São Paulo/Sp

 

 

Country :

Brazil

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

22.10.1998

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Manufacture and sale of pharmaceuticals

 

 

No. of Employees :

1480

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

Usd 1.000.000,00

Status :

Good

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Brazil

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


Company name

 

CIMED INDÚSTRIA DE MEDICAMENTOS LTDA

 

 

company ADDRESSES

 

MAIN ADDRESS:

RUA ENGENHEIRO PRUDENTE, 121 - VILA MONUMENTO

ZIP CODE/CITY:

01550-000 - SÃO PAULO/SP

 

 

PHONE:

11 3544-7200

FAX:

11 3544-7200

E-MAIL:

executivo.gerencia@grupocimed.com.br   

WEB SITE:

www.cimed.ind.br

 

BRANCHES:

 

 

 

ADDRESS:

AVENIDA ANGÉLICA, 2248 - 5º, 6º E 7º ANDARES - CONSOLAÇÃO

ZIP CODE/CITY:

01228-200 SÃO PAULO/SP

CNPJ:

02.814.497/0003-79

 

 

ADDRESS:

RUA CORONEL ARMANDO RUBENS STORINO, 2750 UNIDADE INDUSTRIAL I - BAIRRO DO ALGODÃO

ZIP CODE/CITY:

37550-000 POUSO ALEGRE/MG

PHONE:

35 2102-2000

FAX:

35 2102-2000

CNPJ:

02.814.497/0002-98

 

 

ADDRESS:

RUA GONZALES PECOTCHE, 284 - ARISTOCRATA

ZIP CODE/CITY:

83030-200 SÃO JOSÉ DOS PINHAIS/PR

CNPJ:

02.814.497/0004-50

 

 

ADDRESS:

RODOVIA SC 401 - KM 5 - Nº. 4756 - CENTRO EMPRESARIAL OFFICE PARK - SACO GRANDE

ZIP CODE/CITY:

88032-005 FLORIANÓPOLIS/SC

CNPJ:

02.814.497/0005-30

 

 

ADDRESS:

AVENIDA MARGINAL PROJETADA, 1652 GALPÃO 08 JARDIM MUTINGA

ZIP CODE/CITY:

06463-400 BARUERI/SP

 

 

LEGAL DATA

 

MAIN ACTIVITIES:

 

MANUFACTURE AND SALE OF PHARMACEUTICALS.

 

 

LEGAL FORM:

LIMITED LIABILITY COMPANY

 

 

INCORPORATION DATE:

22/10/1998

REGISTER DATE:

22/10/1998

BALANCE SHEET FILING DATE:

31/12

TAX CONTRIBUTOR NUMBER(CNPJ):

02.814.497/0001-07

STATE REGISTER:

115.980.771.110

 

 

SHARE CAPITAL:

R$ 34.038.000,00

LAST REGISTER OF CAPITAL:

30/05/2008

 

BOARD OF DIRECTORS:

 

 

 

JOÃO DE CASTRO MARQUES

MANAGING PARTNER

JOÃO ADIBE ZACHARIAS MARQUES

MANAGING PARTNER

KARLA MARQUES FELMANAS

MANAGING PARTNER

MARIANA ZACHARIAS MARQUES BARBOSA

MANAGING PARTNER

 

 

AUTHORIZED USE OF SIGNATURE

 

THE MANAGING PARTNERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY.

 

SHAREHOLDERS / PARTNERS:

 

 

 

JOÃO DE CASTRO MARQUES

R$ 19.888.403,00

JOÃO ADIBE ZACHARIAS MARQUES

R$  9.050.704,00

KARLA MARQUES FELMANAS

R$  4.081.157,00

MARIANA ZACHARIAS MARQUES BARBOSA

R$  1.017.736,00

 

AFFILIATES / SUBSIDIARIES:

 

 

 

NECKERMAN INDÚSTRIA FARMACÊUTICA LTDA

 

ADIBE & CASTRO LTDA

 

INSTITUTO CLAUDIA MARQUES DE PESQUISA E DESENVOLVIMENTO LTDA

 

LOGAN DISTRIBUIDORA HOSPITALAR LTDA

 

DISPROFAR COMÉRCIO LTDA

 

DISTRIBUIDORA DE MEDICAMENTOS CASTRO & MARQUES LTDA

 

ABRANGE MERCANTIL FARMACÊUTICA LTDA

 

NUTRACOM INDUSTRIA E COMERCIO LTDA

 

KMG DISTRIBUIDORA FARMACÊUTICA LTDA

 

KMG FARMA LTDA

 

PREDILETA DISTRIBUIDORA MEDICAMENTOS LTDA (PB)

 

PREDILETA DISTRIBUIDORA MEDICAMENTOS LTDA (RN)

 

PREDILETA GOIÁS DISTRIBUIDORA DE MEDICAMENTOS LTDA

 

PREDILETA MARANHÃO DISTRIBUIDORA DE MEDICAMENTOS LTDA

 

PREDILETA PARÁ DISTRIBUIDORA DE MEDICAMENTOS LTDA

 

PREDILETA RIO DE JANEIRO DISTRIBUIDORA DE MEDICAMENTOS LTDA

 

PREDILETA TOCANTINS DISTRIBUIDORA DE MEDICAMENTOS LTDA

 

SIFARMA SIMILARES FARMACÊUTICOS LTDA

 

COMPANY'S BACKGROUND

 

THE SUBJECT WAS ESTABLISHED ON OCTOBER 22, 1998 AS CIMED INDÚSTRIA DE MEDICAMENTOS S/A TO BE ENGAGED IN THE SAID LINE OF BUSINESS. LATER IT ADOPTED THE ABOVE MENTIONED NAME.

 

TRADE NAME: "CIMED".

 

PARTNERS:

 

JOÃO DE CASTRO MARQUES: BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS RG 3718471 SP, CPF 232.877.308-780, RESIDENTIAL ADDRESS AT RUA ENGENHEIRO EDGARD EGIDIO DE SOUSA 303, APTO 31, PACAEMBU, ZIP CODE 01233-020, SÃO PAULO/SP;

 

JOÃO ADIBE ZACHARIAS MARQUES: BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS RG 14600581 SP, CPF 129.633.008-75, RESIDENTIAL ADDRESS AT RODOVIA HAROLDO SOARES GLAVAN 4450, CASA 05, CACUPE, ZIP CODE 88050-005, FLORIANOPOLIS/SC;

 

KARLA MARQUES FELMANAS: BRAZILIAN, DIVORCED, HOLDER OF DOCUMENTS RG 14.600.582-X SP, CPF 128.260.488-05, RESIDENTIAL ADDRESS AT RUA MELO MORAIS FILHO 169, JARDIM GUEDALA, ZIP CODE 05610-040, SÃO PAULO/SP;

 

MARIANA ZACHARIAS MARQUES BARBOSA: BRAZILIAN, MARRIED, HOLDER OF DOCUMENTS RG 18.190-178-X SP, CPF 166.310.298-80, RESIDENTIAL ADDRESS AT RUA DR. SERAFICO DE ASSIS CARVALHO 103, APTO 74, JARDIM LEONOR, ZIP CODE 05614-040, SÃO PAULO/SP;

 

FURTHER DETAILS ABOUT THE SUBJECT'S HISTORY ARE SO FAR NOT KNOWN.

 

PUBLIC INFORMATION:

 

NO DETRIMENTAL FILES WERE FOUND.

 

 

FINANCIAL INFORMATION

 

GENERAL BALANCE SHEETS AS OF 31/12/2010, 31/12/2009 AND 31/12/2008.

( FIGURES ARE IN REAIS ).

 

ASSETS

 

 

 

CURRENT:

31/12/2010

31/12/2009

31/12/2008

 

 

 

 

CASH AND CASH EQUIVALENTS

1.193.225,43

1.271.837,17

988.895,13

CLIENTS

65.694.627,78

46.681.363,85

48.861.115,27

INVENTORY

12.725.886,72

20.818.200,10

24.908.880,06

RECOVERABLE TAXES

1.182.370,67

917.284,14

236.270,94

PRE PAID EXPENSES

216.099,35

157.517,07

140.856,35

OTHER CREDITS

1.919.626,77

1.303.720,02

1.814.785,23

 

----------------

----------------

----------------

TOTAL CURRENT ASSETS

82.931.836,72

71.149.922,35

76.950.802,98

 

LONG-TERM RECEIVABLES:

 

 

 

 

 

 

 

CREDITS

369.392,74

221.901,25

178.913,94

RECOVERABLE TAXES

39.469,69

141.980,86

217.068,40

 

----------------

----------------

----------------

TOTAL LONG-TERM RECEIVABLES

408.862,43

363.882,11

395.982,34

 

FIXED ASSETS:

 

 

 

 

 

 

 

INVESTMENTS

13.497.737,14

11.548.186,91

11.514.632,24

FIXED ASSETS

42.724.851,45

19.519.213,22

13.447.143,45

 

----------------

----------------

----------------

TOTAL FIXED ASSETS

56.222.588,59

31.067.400,13

24.961.775,69

 

================

================

================

TOTAL ASSETS

139.563.287,74

102.581.204,59

102.308.561,01

 

LIABILITIES:

 

 

 

CURRENT:

31/12/2010

31/12/2009

31/12/2008

 

 

 

 

SUPPLIERS

6.062.990,33

3.177.025,48

5.270.039,92

FOREIGN SUPPLIERS

3.223.837,35

1.256.005,16

9.328.957,14

BANKING DEBTS

35.281.343,68

18.877.357,16

28.888.233,15

TAXES & CONTRIBUTIONS

3.006.163,88

2.708.875,31

1.884.635,40

SALARIES PAYABLE

4.324.416,65

3.306.389,28

3.834.739,23

INTERCOMPANY DEBTS

5.094.997,22

1.198.706,09

12.653.918,01

COMMISSIONS DUE

765.310,18

684.337,41

 

OTHER DEBTS

2.294.650,00

450.000,00

1.355.831,51

 

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

60.053.709,29

31.658.695,89

63.216.354,36

 

LONG TERM LIABILITIES:

 

 

 

 

 

 

 

LOANS AND FINANCING

18.266.112,31

7.204.408,85

6.954.017,66

TAXES AND CONTRIBUTIONS

1.538.430,76

1.510.461,45

1.744.921,24

DEBT WITH PARTNERS

9.164.587,08

14.371.404,27

 

 

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

28.969.130,15

23.086.274,57

8.698.938,90

 

NET EQUITY:

 

 

 

 

 

 

 

SHARE CAPITAL

34.038.000,00

34.038.000,00

24.620.000,00

ACCRUED PROFIT (LOSS)

 

11.967.608,33

9.402.932,54

PROFIT SHARING

-367.714,93

-2.650.975,24

-2.505.519,95

PROFIT (LOSS) OF PERIOD

 

4.481.601,04

-1.124.144,84

PROFIT RESERVES

16.870.163,23

 

 

 

----------------

----------------

----------------

TOTAL NET EQUITY

50.540.448,30

47.836.234,13

30.393.267,75

 

================

================

================

TOTAL LIABILITIES

139.563.287,74

102.581.204,59

102.308.561,01

 

PROFIT AND LOSS ACCOUNTS AS OF 31/12/2010, 31/12/2009 AND 31/12/2008.

( FIGURES ARE IN REAIS ).

 

 

31/12/2010

31/12/2009

31/12/2008

 

 

 

 

GROSS SALES

219.971.792,86

182.899.773,33

175.405.890,34

(-) TAXES ON SALES

48.322.343,43

42.480.914,34

36.056.489,71

 

----------------

----------------

----------------

NET SALES

171.649.449,43

140.418.858,99

139.349.400,63

(-) COST OF SOLD GOODS

94.224.504,03

66.578.326,04

75.301.063,48

 

----------------

----------------

----------------

GROSS PROFIT

77.424.945,40

73.840.532,95

64.048.337,15

OPERATING REVENUE (EXPENSE)

-62.161.209,86

-60.919.786,08

-57.695.716,63

FINANCIAL REVENUE(EXPENSE)

-13.070.604,80

-8.425.680,44

-6.978.429,96

 

----------------

----------------

----------------

OPERATIONAL PROFIT (LOSS)

2.193.130,74

4.495.066,43

-625.809,44

NON-OPERATING RESULT

878.798,36

-13.465,39

-498.335,40

 

----------------

----------------

----------------

NET PROFIT (LOSS)

3.071.929,10

4.481.601,04

-1.124.144,84

 

MONTHLY SALES

 

  2011

 

 

 

---------------------

 

 

JANUARY

R$ 5.431.546,00

 

 

FEBRUARY

R$ 8.757.202,00

 

 

MARCH

R$ 26.889.489,00

 

 

APRIL

R$ 25.353.803,00

 

 

MAY

R$ 26.644.211,00

 

 

JUNE

 

 

 

JULY

 

 

 

AUGUST

 

 

 

SEPTEMBER

 

 

 

OCTOBER

 

 

 

NOVEMBER

 

 

 

DECEMBER

 

 

 

TOTAL

R$ 93.076.251,00

 

 

 

RATIOS:

31/12/2010

31/12/2009

31/12/2008

 

QUICK RATIO

1,17

 

1,59

 

,82

 

CURRENT RATIO

1,38

 

2,25

 

1,22

 

ACCOUNTS RECEIVABLE TURNOVER

2,61

TIMES

3,01

TIMES

2,85

TIMES

DAYS' SALES IN RECEIVABLES

137,78

DAYS

119,68

DAYS

126,23

DAYS

INVENTORY TURNOVER

7,40

TIMES

3,20

TIMES

3,02

TIMES

ACCOUNTS PAYABLE PERIOD

23,16

DAYS

17,18

DAYS

25,20

DAYS

RETURN ON ASSETS

1,23

TIMES

1,37

TIMES

1,36

TIMES

SALES TURNOVER ON NET EQUITY

3,40

TIMES

2,94

TIMES

4,58

TIMES

NET WORTH TIE-UP

,85

 

,41

 

,44

 

INDEBTEDNESS

1,76

 

1,14

 

2,37

 

EQUITY RATIO

36,21

%

46,63

%

29,71

%

WORKING CAPITAL RATIO

38,10

%

124,74

%

21,73

%

GENERAL SOLVENCY

1,57

 

1,87

 

1,42

 

RETURN ON NET EQUITY

6,08

%

9,37

%

-3,70

%

RETURN ON SALES (PROFIT MARGIN)

1,79

%

3,19

%

-,81

%

GROSS PROFIT MARGIN

45,11

%

52,59

%

45,96

%

OPERATIONAL RESULT

1,28

%

3,20

%

-,45

%

SALES TURNOVER ON LIABILITIES

2,86

TIMES

4,44

TIMES

2,20

TIMES

FOREIGN CURRENCY ON ASSETS

 

 

 

 

 

 

FOREIGN CURRENCY ON LIABILITIES

 

 

 

 

 

 

 

EXCHANGE RATE:

 

 

US$ 1,00 = R$ 1,81

 - OFFICIAL RATE ON 30/11/2011

US$ 1,00 = R$ 1,66

 - OFFICIAL RATE ON 31/12/2010

US$ 1,00 = R$ 1,74

 - OFFICIAL RATE ON 31/12/2009

US$ 1,00 = R$ 2,33

 - OFFICIAL RATE ON 31/12/2008

 

COMMENTS ON THE FINANCIAL INFORMATION:

 

FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS.

 

THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE LEVEL OF INDEBTEDNESS IS HIGH AND MAINLY IS COMPRISED BY FINANCIAL DEBTS. DESPITE THIS IT HAS GOOD LIQUIDITY RATIOS AND WORKING CAPITAL, CONSIDERED SUFFICIENT TO COVER THE SHORT-TERM LIABILITIES. IT SHOWS HIGH AND GROWING SALES AND MADE PROFIT.

 

REAL ESTATE:

THE PARTNERS OWN REAL ESTATE VALUED AT R$ 2.399.175,00

 

VEHICLES:

NOT AVAILABLE

 

MACHINES:

NOT AVAILABLE

 

 

INSURANCE

 

NOT AVAILABLE.

 

 

BANKING REFERENCES

 

 

BRANCH/PHONE:

 

BANCO DO BRASIL S/A

3322 / 11 2065-4055

 

BANCO BRADESCO S/A

0138 / 11 2178-4280

 

BANCO ITAÚ S/A

0676 / 11 3708-2687

 

 

REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS.

 

ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682 BRAZILIAN CENTRAL BANK").

 

 

ACTIVITIES COMMENTS

 

SUBJECT IS ENGAGED IN THE MANUFACTURE AND SALE OF PHARMACEUTICALS.

 

IMPORT AND EXPORT:

 

IMPORTS FROM:

UNITED STATES, SWITZERLAND, ITALY, GERMANY, CYPRUS AND MEXICO.

 

EXPORTS TO:

NOT AVAILABLE.

 

MAIN CLIENTS:

 

 

 

 

 

DOMESTIC CLIENTS:

 

 

DEMAC PRODUTOS FARMACÊUTICOS LTDA

 

 

DROG MAIS ECONÔMICA LTDA

 

 

EMPREENDIMENTOS PAGUE MENOS

 

 

 

STAFF:

 

THE COMPANY HAS: 1480 EMPLOYEE(S)

 

 

CONCEPT AND FULFILMENT

 

THE SUBJECT IS A WELL-ESTABLISHED COMPANY OPERATING SINCE 1998. SO FAR IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOUR.

 

THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED.

 

MAIN SUPPLIERS:

 

 

 

 

 

DOMESTIC SUPPLIERS:

 

PHONE:

ART PACK EMBALAGENS LTDA

 

 

BRASÍLIA MÁQUINAS E FERRAMENTAS LTDA

 

11 6097-8500

C A S IMP. EXP. LTDA

 

11 5677-9696

DAMATEC CORREIAS INDUSTRIAIS LTDA

 

11 6421-7752

IMPACTA S/A. INDÚSTRIA E COMÉRCIO

 

 

INDURKERN DO BRASIL QUÍMICA LTDA

 

11 3689-7676

M CASSAB COMÉRCIO E INDÚSTRIA LTDA

 

11 5522-7788

ORBIS INDUSTRIAL E COMERCIO LTDA

 

 

OWENS ILLINOIS DO BRASIL S/A

 

 

RINEPLAST PLASTICOS RIO NEGRINHO LTDA

 

 

SHELLMAR EMBALAGEM MODER LTDA

 

11 4128-5200

SOUFER INDUSTRIAL LTDA

 

19 3634-3600

VALDEQUÍMICA PRODUTOS QUÍMICOS LTDA

 

11 3721-6407

 

PAYMENT HISTORY:

 

17 SUPPLIERS REPORTED PAYMENTS:

   TOTAL AMOUNT:  R$ 1.314.373,00

 

AMOUNT OF INVOICES PAID: 353

TOTAL OF PROMPT PAYMENTS: 82,4%

TOTAL OF DELAYED PAYMENTS: 17,6%

 

HIGHEST INVOICE: R$ 56.032,00

HIGHEST CREDIT: R$ 56.032,00

 

OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS:

 

---------------------------

SUPPLIERS:

INVOICES:

TOTAL AMOUNT:

DUE WITHIN 30 DAYS

1

7

R$ 16.707,48

DUE WITHIN 60 DAYS

1

1

R$ 1.250,00

 

 

FINAL OPINION

 

THE SUBJECT HAS BEEN IN BUSINESS SINCE 1998. UP TO DATE IT HAS A CLEAR TRADE HISTORY AND GOOD PAYMENT BEHAVIOR.

 

BASED ON THE GENERAL INFORMATION AVAILABLE ITS IS BELIEVED THAT GOOD TRADE RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH.

 

A CREDIT LIMIT OF USD 1.000.000,00 MAY BE CONSIDERED.

 


CIMED INDÚSTRIA DE MEDICAMENTOS LTDA

BALANCE SHEET ANALYSIS

FIGURES ARE IN REAIS

 

 

 

 

 

 

31-12-10

 

31-12-09

 

31-12-08

 

ASSETS

 

%

 

%

 

%

Current Assets

 $            82,931,837

59.42

 $            71,149,922

69.36

 $        76,950,803

75.21

Fixed Assets

 $            56,222,589

40.28

 $            31,067,400

30.29

 $        24,961,776

24.40

TOTAL ASSETS

 $          139,563,288

100.00

 $          102,581,205

100.00

 $      102,308,561

100.00

LIABILITIES

 

 

 

 

 

 

Current Liabilities

 $            60,053,709

43.03

 $            31,658,696

30.86

 $        63,216,354

61.79

Long-Term Liabilities

 $            28,969,130

20.76

 $            23,086,275

22.51

 $          8,698,939

8.50

TOTAL LIABILITIES

 $            89,022,839

63.79

 $            54,744,970

53.37

 $        71,915,293

70.29

Deferred Income

 $                            -  

0.00

 $                            -  

0.00

 $                        -  

0.00

Net Equity

 $            50,540,448

36.21

 $            47,836,234

46.63

 $        30,393,268

29.71

TOTAL LIABILITIES + NET EQUITY

 $          139,563,288

100.00

 $          102,581,205

100.00

 $      102,308,561

100.00

PROFIT AND LOSS ACCOUNTS

 

 

 

 

 

 

Net Sales

 $          171,649,449

100.00

 $          140,418,859

100.00

 $      139,349,401

100.00

Costs

 $            94,224,504

54.89

 $            66,578,326

47.41

 $        75,301,063

54.04

Gross Profit

 $            77,424,945

45.11

 $            73,840,533

52.59

 $        64,048,337

45.96

Operating expenses

 $          (62,161,210)

-36.21

 $          (60,919,786)

-43.38

 $      (57,695,717)

-41.40

operational Result

 $              2,193,131

1.28

 $              4,495,066

3.20

 $            (625,809)

-0.45

Net Profit (loss)

 $              3,071,929

1.79

 $              4,481,601

3.19

 $         (1,124,145)

-0.81

COMPLEMENTARY DATA

 

 

 

 

 

 

Inventory

 $            12,725,887

 

 $            20,818,200

 

 $        24,908,880

 

Accounts receivable

 $            65,694,628

 

 $            46,681,364

 

 $        48,861,115

 

Accounts Payable

 $              6,062,990

 

 $              3,177,025

 

 $          5,270,040

 

Property, plant and equipment

 $            42,724,851

 

 $            19,519,213

 

 $        13,447,143

 

Purchases

 $            56,222,589

 

 $            31,067,400

 

 $        24,961,776

 

Financial Expenses

 $          (13,070,605)

 

 $             (8,425,680)

 

 $         (6,978,430)

 

Foreign Currency Assets

 

 

 

 

 

 

Foreign Currency Liabilities

 

 

 

 

 

 

Working Capital

 $            22,878,127

 

 $            39,491,226

 

 $        13,734,449

 

RATIOS:

 

 

 

 

 

 

QUICK RATIO

                           1.17

 

                           1.59

 

                       0.82

 

CURRENT RATIO

                           1.38

 

                           2.25

 

                       1.22

 

ACCOUNTS RECEIVABLE TURNOVER

                           2.61

times

                           3.01

times

                       2.85

times

DAYS' SALES IN RECEIVABLES

                       137.78

days

                       119.68

days

                   126.23

days

INVENTORY TURNOVER

                           7.40

times

                           3.20

times

                       3.02

times

ACCOUNTS PAYABLE PERIOD

                         23.16

days

                         17.18

days

                     25.20

days

RETURN ON ASSETS

                           1.23

times

                           1.37

times

                       1.36

times

SALES TURNOVER ON NET EQUIY

                           3.40

times

                           2.94

times

                       4.58

times

NET WORTH TIE-UP

                           0.85

 

                           0.41

 

                       0.44

 

ENDEBTEDNESS

                           1.76

 

                           1.14

 

                       2.37

 

EQUITY RATIO

                         36.21

%

                         46.63

%

                     29.71

%

WORKING CAPITAL RATIO

                         38.10

%

                       124.74

%

                     21.73

%

GENERAL SOLVENCY

                           1.57

 

                           1.87

 

                       1.42

 

RETURN ON NET EQUITY

                           6.08

%

                           9.37

%

                      (3.70)

%

RETURN ON SALES (PROFIT MARGIN)

                           1.79

%

                           3.19

%

                      (0.81)

%

GROSS PROFIT MARGIN

                         45.11

%

                         52.59

%

                     45.96

%

OPERATIONAL RESULT

                           1.28

%

                           3.20

%

                      (0.45)

%

SALES TURNOVER ON LIABILITIES

                           2.86

times

                           4.44

times

                       2.20

times

FOREIGN CURRENCY ON ASSETS

                               -  

%

                               -  

%

                           -  

%

FOREIGN CURRENCY ON LIABILITIES

                               -  

%

                               -  

%

                           -  

%

 

 

 


 

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.90

UK Pound

1

Rs.78.15

Euro

1

Rs.65.09

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.